RankingsPricing
  1. US-listed companies
  2. AMGEN INC
  3. Financials
  4. Capital expenditures

AMGEN INCAMGN

Market cap
$174.4B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-1,096-1.44%
Dec 31, 2023-1,112+18.80%
Dec 31, 2022-936+6.36%
Dec 31, 2021-880+44.74%
Dec 31, 2020-608-1.62%
Dec 31, 2019-618-16.26%
Dec 31, 2018-738+11.14%
Dec 31, 2017-664-10.03%
Dec 31, 2016-738+24.24%
Dec 31, 2015-594-17.27%
Dec 31, 2014-718+3.61%
Dec 31, 2013-693+0.58%
Dec 31, 2012-689+21.52%
Dec 31, 2011-567-2.24%
Dec 31, 2010-580

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)